Is Gleason Grade 5 Prostate Cancer Resistant to Conventional Androgen Deprivation Therapy?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 26364550.
- Also identified by DOI 10.1016/j.eururo.2015.08.057.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Synthesis of data from randomized trials suggests that long-term versus short-term androgen deprivation therapy may be most effective in men with Gleason grade 4 prostate cancer (PCa) and less or ineffective in men with Gleason grade 5 PCa.
Medical subject headings
- Androgen Receptor Antagonists
- Luteinizing Hormone
- Neoplasm Grading
- Prostatic Neoplasms